Oxford Biomedica plc (LON:OXB)

Market Cap	784.79M
Revenue (ttm)	151.21M
Net Income (ttm)	-37.07M
Shares Out	120.18M
EPS (ttm)	-0.36
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	148,627
Average Volume	359,103
Open	660.00
Previous Close	653.00
Day's Range	636.00 - 660.00
52-Week Range	232.50 - 656.00
Beta	0.95
RSI	67.27
Earnings Date	Sep 23, 2025

About Oxford Biomedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and de...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1996
• Employees: 850
• Stock Exchange: London Stock Exchange
• Ticker Symbol: OXB

Financial Performance

In 2024, Oxford Biomedica's revenue was 128.80 million, an increase of 43.84% compared to the previous year's 89.54 million. Losses were -43.19 million, -72.58% less than in 2023.